Cargando…

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions

Background: The objective of this study was to assess the safety and performance of the Omnipod(®) personalized model predictive control (MPC) algorithm in adults, adolescents, and children aged ≥6 years with type 1 diabetes (T1D) under free-living conditions using an investigational device. Materia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherr, Jennifer L., Buckingham, Bruce A., Forlenza, Gregory P., Galderisi, Alfonso, Ekhlaspour, Laya, Wadwa, R. Paul, Carria, Lori, Hsu, Liana, Berget, Cari, Peyser, Thomas A., Lee, Joon Bok, O'Connor, Jason, Dumais, Bonnie, Huyett, Lauren M., Layne, Jennifer E., Ly, Trang T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047109/ https://www.ncbi.nlm.nih.gov/pubmed/31596130 http://dx.doi.org/10.1089/dia.2019.0286

Ejemplares similares

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes
por: Buckingham, Bruce A., et al.
Publicado: (2018)

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2019)

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm
por: Buckingham, Bruce A., et al.
Publicado: (2018)

Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes
por: Berget, Cari, et al.
Publicado: (2022)

The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
por: Bode, Bruce W, et al.
Publicado: (2021)

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
por: Davis, Georgia M., et al.
Publicado: (2023)

First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2021)

Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers
por: Ekhlaspour, Laya, et al.
Publicado: (2021)

Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)
por: Buckingham, Bruce A, et al.
Publicado: (2021)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2021)

Glycemic Control and Factors Impacting Treatment Choice in Tubeless Insulin Pump Users: A Survey of the T1D Exchange Glu Online Community
por: Layne, Jennifer E., et al.
Publicado: (2019)

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018)

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial
por: Sherr, Jennifer L., et al.
Publicado: (2022)

Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607–615
por: Kovatchev, Boris, et al.
Publicado: (2020)

Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment
por: Pinsker, Jordan E., et al.
Publicado: (2022)

Initiating hybrid closed loop: A program evaluation of an educator‐led Control‐IQ follow‐up at a large pediatric clinic
por: Messer, Laurel H., et al.
Publicado: (2021)

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
por: Zisser, Howard C.
Publicado: (2010)

Barriers to Uptake of Insulin Technologies and Novel Solutions
por: Pauley, Meghan E, et al.
Publicado: (2021)

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
por: Weinzimer, Stuart A., et al.
Publicado: (2012)

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2013)

Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
por: Forlenza, Gregory P., et al.
Publicado: (2022)

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
por: DeSalvo, Daniel J., et al.
Publicado: (2015)

Canadian Real‐World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry
por: Brown, R. E., et al.
Publicado: (2020)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
por: Sherr, Jennifer L., et al.
Publicado: (2014)

Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms
por: Doyle, Francis J., et al.
Publicado: (2014)

Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096–1102
por: Forlenza, Gregory P., et al.
Publicado: (2017)

Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days
por: DeSalvo, Daniel J., et al.
Publicado: (2016)

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)
por: Howsmon, Daniel P., et al.
Publicado: (2017)

Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System
por: Aleppo, Grazia, et al.
Publicado: (2023)

Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults
por: Sherr, Jennifer L.
Publicado: (2018)

Response to Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197
por: Doyle, Francis J., et al.
Publicado: (2014)

Team Clinic: Group Approach to Care of Early Adolescents With Type 1 Diabetes
por: McClain, Megan Rose, et al.
Publicado: (2018)

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study
por: Breton, Marc D., et al.
Publicado: (2017)

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
por: Brown, Sue A., et al.
Publicado: (2021)

A pilot randomised controlled parallel arm trial evaluating treatment satisfaction with the Omnipod DASH(®) Insulin Management System compared with usual care in adults with type 1 diabetes in Australia: rationale, study design and methodologies
por: Kong, Yee Wen, et al.
Publicado: (2023)

Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
por: Cordero, Toni L., et al.
Publicado: (2023)

A Novel Approach to Adolescents With Type 1 Diabetes: The Team Clinic Model
por: Raymond, Jennifer K., et al.
Publicado: (2015)

Radioactive Phosphorus in the Diagnosis of Gastrointestinal Cancer
por: Sangree, M. Huyett
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_n26fgh2ad3sb96b80isuvdir04